Spectranetics Corporation (NASDAQ:SPNC) today announced it will showcase a new advanced Laser Lead Extraction Simulation system at the Heart Rhythm Society's (HRS) 31st Annual Scientific Sessions, Heart Rhythm 2010. The new simulation system is intended to augment traditional procedural training for physicians on laser-assisted lead extraction procedures by permitting hands-on practice with extraction tools and techniques in multiple case scenarios in a virtual operating environment.
“Of all the procedures I do, lead extraction has the steepest and longest learning curve. Many studies have now demonstrated that in experienced hands extraction is a safe and effective approach to lead management”
Due in part to the large and growing number of leads to manage in patients implanted with pacemakers and defibrillators, in May 2009 HRS updated its expert consensus recommendations for lead extraction. Acknowledging the challenge for physicians to achieve the desired volume of proctored cases in a training regime, HRS experts highlighted lead extraction simulation with realistic scenarios as an important future component of initial hands-on exposure and subsequent maintenance of skills. One year later, Spectranetics is demonstrating its continuing commitment to training, education, and patient outcomes by delivering a solution toward the objectives outlined by HRS.
Spectranetics has partnered with Medical Simulation Corporation (MSC) to develop the customized Laser Lead Extraction Simulation in conjunction with MSC's SimSuite® simulation technology platform. The simulation system features simulated patient scenarios that allow physicians to manipulate lead extraction tools with tactile feedback and visual diagnostics such as "virtual" x-ray imagery that closely mimics real-world patient scenarios. Physicians are able to experience the force interactions coinciding with successful techniques and encounter potential complications to learn avoidance and management skills. The simulation system specifically incorporates use of the Spectranetics SLS® II Laser Sheath, LLD EZ® Lead Locking Device and VisiSheath® Dilator Sheath in the lead extraction process.
"Of all the procedures I do, lead extraction has the steepest and longest learning curve. Many studies have now demonstrated that in experienced hands extraction is a safe and effective approach to lead management," said Dr. Laurence Epstein, Chief of Cardiac Arrhythmia Services at Brigham and Women's Hospital. "Unfortunately the ability for physicians to receive robust training is limited. The old approach of 'see one, do one, teach one' does not provide the experience experts feel is important, therefore the availability of a realistic simulator is a major step forward in physician training and thereby improved patient outcomes."
Leads, or insulated wires that connect devices to the heart, may become non-functional or infected resulting in the need for removal. As scar tissue can bind the leads in several places along their length, removing cardiac leads can be challenging and requires proper training in extraction techniques and management of potential complications. Spectranetics provides its excimer laser sheath technology to vaporize the binding scar tissue, thereby freeing the leads for removal.
"As an increasing number of patients are implanted with cardiac devices, there is a growing need for experienced physicians to manage the issues that arise with the leads in these systems," said Emile J. Geisenheimer, Chairman, President and Chief Executive Officer of Spectranetics. "The Laser Lead Extraction Simulation system further demonstrates our commitment to providing physicians with tools to assist them in achieving safe and effective patient outcomes and making high-quality lead extraction therapy available to the millions of patients who need access."
The Laser Lead Extraction Simulation system, along with Spectranetics' Lead Management solutions, can be viewed at Booth 1613 at Heart Rhythm 2010 Exhibit, which is taking place May 13-15, 2010 at the Colorado Convention Center in Denver, Colorado. Simulation opportunities for physicians will become available this summer through a variety of educational forums.
Hypertension drug may reduce heart failure risk in people recovering from heart attack